Alfred L. Garfall, MD, assistant professor of medicine, Perelman School of Medicine, University of Pennsylvania, provides insight on the FDA approval of daratumumab (Darzalex) added to bortezomib (Velcade), thalidomide (Thalomid), and dexamethasone (VTd) for the treatment of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant.

Website: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
LinkedIn: [ Ссылка ]

свернуть